-
Product Insights
Colitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Colitis - Drugs In Development, 2023’, provides an overview of the Colitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Colitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IA-14069 in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IA-14069 in Rheumatoid Arthritis Drug Details:IA-14069 is under development for the treatment of rheumatoid arthritis, colitis...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IA-14069 in Colitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IA-14069 in ColitisDrug Details:IA-14069 is under development for the treatment of rheumatoid arthritis, colitis and unspecified...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NA-0116 in Endometriosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NA-0116 in Endometriosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NA-0116 in EndometriosisDrug Details:NA-0116 is under development for the treatment of mild to moderate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-001 in DiGeorge Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-001 in DiGeorge Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NB-001 in DiGeorge Syndrome Drug Details: Fasoracetam monohydrate is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSC-101 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSC-101 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TSC-101 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic...
-
Product Insights
Electrophysiology Lab Systems – Boston Scientific Corp – ILAB
GlobalData, the industry analysis specialist, has released its latest report: Electrophysiology Lab Systems - Boston Scientific Corp - ILAB. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IA-14069
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry IA-14069 Drug Details IA-14069 is under development for the treatment of rheumatoid arthritis, colitis...